Zepto® has been demonstrated in a FDA clinical trial to be safe and effective.  No change in corneal incision size was observed after Zepto use in 70% of cases, and a mean enlargement of 30 micron was encountered in 30% of cases.  No differences in ocular condition have been observed after Zepto use compared to CCC, with a peak temperature increase of 1-2°C for a fraction of a second.

View Miyake-Apple Imaging of Zonular Tissue During Zepto Use

View Temperature Testing and Data Sheet

Download Peer Reviewed Publication of Zepto Capsulotomy Strength Testing

Download Peer Reviewed Publication with Zepto Product Performance Review

NEWS

18 May ESCRS Lisbon 2017 David Chang Interview about Zepto with TheOphthalmologist Dr. David Chang Discusses Zepto Capsulotomy System for Cataract ... read more ›
16 May ESCRS Lisbon 2017 Walter Sekundo Interview on Zepto with TheOphthalmologist Discussing Zepto Precision Capsulotomy by Mynosys with Dr. Walter ... read more ›
03 May Zepto to be Featured in Multiple Sessions at AECOS in Berlin Mynosys will be sponsoring and exhibiting at the upcoming European ... read more ›

FEATURED VIDEO